Posted: 2023-04-03

Our spin-off company, Sustained Therapeutics, has developed a soft polymer gel that is being clinically tested to deliver pain relieving drugs via local injection to targeted sites in the body in a highly controlled manner. The gel is designed to release the medication slowly, potentially providing relief over days, weeks, or even months. This technology may have other uses for treating fibrotic and inflammatory diseases, cancer, and more.

Posted: 2023-02-15

Congratulations to Drs. Michael Cox, Kish Wasan, Nathan Lack, Syam Somasekharan and their teams on being awarded the 5 year Canadian Institutes of Health Research (CIHR) Project Grant for an amount of C$ 956,250.00. The grant is titled, 'Understanding epigenetic regulation and modulation of cell stress responses by the cholesterol transporter, scavenger receptor-B1 as a novel target for treating advanced prostate cancer.'

Posted: 2022-12-07

Congratulations to Dr Stephen Choi, a postdoctoral cancer researcher in the Urologic Sciences Department at the University of British Columbia, who is earning the Mitacs Award for Outstanding Innovation — Postdoctoral for his work to develop a groundbreaking treatment for prostate cancers. Turning conventional wisdom on its head, Choi discovered that suppressing lactic acid, a byproduct generated by cancer cells, can prevent cancer from spreading. His work is now being used to develop an innovative, low-cost drug therapy.

Posted: 2022-11-29

Congratulations to the VPC team led by Dr. Amina Zoubeidi on receiving a successful team grant for a 2022 New Frontiers Program Project Grant from The Terry Fox Research Institute.

Posted: 2022-11-15

Congratulations to Dr. Martin Gleave who received the Mostafa M. Elhilali Award at the SIU in Montreal! Every year, during the SIU Annual Congress, the Society recognizes outstanding contributions to the Society, and the field of urology through the presentation of various awards. This award in particular is given to a scientist of excellent scientific and ethical standing.

Posted: 2022-10-06

Congratulations to Dr. Lucia Nappi, PI of the research project: “Detection of early relapse using circulating miR371a-3p in patients with early stage testicular germ cell tumors” which received a three year, $622,872 USD US Department of Defense – Peer Reviewed Cancer Research Program in the category of Career Development Award.

Posted: 2022-09-28

Lineage plasticity of prostate cancer is associated with resistance to androgen receptor (AR) pathway inhibition (ARPI) and supported by a reactive tumor microenvironment.

Posted: 2022-09-20

Innovative technology developed by Vancouver Prostate Centre investigator Dr. Mads Daugaard will allow scientists to access cell analytics from anywhere in the world, which could help democratize research and advance the development of personalized medical treatments.

Posted: 2022-09-15

Dr. Kotaro Suzuki joins over 1,400 Research Trainee award holders from Michael Smith Health Research BC who reflect the best and brightest of BC's health research talent.

Dr. Suzuki joined Dr. Martin Gleave’s research team at the Vancouver Prostate Centre in the Department of Urologic Sciences at the University of British Columbia as a postdoctoral research fellow.

Posted: 2022-09-15

Congratulations to Dr Alexander Wyatt on his promotion to Associate Professor, Department of Urologic Sciences, University of British Columbia (UBC).

Recently, Dr Wyatt together with senior medical oncologists and urologists at the Vancouver Prostate Centre and UBC, demonstrated that plasma circulating tumor DNA (ctDNA) is highly representative of metastatic lesions in prostate and bladder cancer.

This promotion reflects Dr Wyatt's contribution in teaching and research, leading to an outstanding research career to date.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.


Work at the Vancouver Prostate Centre

Thursday, January 18, 2024

Dr Artem Cherkasov receives world-wide challenge in drug discovery

Dr. Cherkasov
Wednesday, February 21, 2024

Dr. Somasekharan has been granted a $1.12 million USD from the DOD Award